Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2013 Oct 15;112(8):1158-64.
doi: 10.1016/j.amjcard.2013.05.061. Epub 2013 Jun 28.

Prevalence, clinical characteristics, and outcomes associated with eccentric versus concentric left ventricular hypertrophy in heart failure with preserved ejection fraction

Affiliations
Comparative Study

Prevalence, clinical characteristics, and outcomes associated with eccentric versus concentric left ventricular hypertrophy in heart failure with preserved ejection fraction

Daniel H Katz et al. Am J Cardiol. .

Abstract

Although concentric remodeling (CR) and concentric hypertrophy (CH) are common forms of left ventricular (LV) remodeling in heart failure with preserved ejection fraction (HFpEF), eccentric hypertrophy (EH) can also occur in these patients. However, clinical characteristics and outcomes of EH have not been well described in HFpEF. We prospectively studied 402 patients with HFpEF, divided into 4 groups based on LV structure: normal geometry (no LV hypertrophy [LVH] and relative wall thickness [RWT] ≤0.42); CR (no LVH and RWT >0.42); CH (LVH and RWT >0.42); and EH (LVH and RWT ≤0.42). We compared clinical, laboratory, echocardiographic, invasive hemodynamic, and outcome data among groups. Of 402 patients, 48 (12%) had EH. Compared with CH, patients with EH had lower systolic blood pressure and less renal impairment despite similar rates of hypertension. After adjustment for covariates, EH was associated with reduced LV contractility compared with CH: lower LVEF (β coefficient = -3.2; 95% confidence interval [CI] -5.4 to -1.1%) and ratio of systolic blood pressure to end-systolic volume (β coefficient = -1.0; 95% CI -1.5 to -0.5 mm Hg/ml). EH was also associated with increased LV compliance compared with CH (LV end-diastolic volume at an idealized LV end-diastolic pressure of 20 mm Hg β coefficient = 14.2; 95% CI 9.4 to 19.1 ml). Despite these differences, EH and CH had similarly elevated cardiac filling pressures and equivalent adverse outcomes. In conclusion, the presence of EH denotes a distinct subset of HFpEF that is pathophysiologically similar to HF with reduced EF (HFrEF) and may benefit from HFrEF therapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Distribution of Left Ventricular Geometries in Heart Failure with Preserved Ejection Fraction
Left ventricular hypertrophy was defined as left ventricular mass/height2.7>44g/m2.7 in women and >48 g/m2.7 in men. Concentric geometry defined as RWT > 0.42.CR = concentric remodeling; CH = concentric hypertrophy; EH = eccentric hypertrophy.
Figure 2
Figure 2. Pressure-Volume Relationships in Heart Failure with Preserved Ejection Fraction: Eccentric Hypertrophy versus Concentric Hypertrophy
Patients with eccentric hypertrophy have downward and rightward shifted end-systolic and end-diastolic pressure volume relationships, as indicated by larger ESV120 and EDV20 values.
Figure 3
Figure 3. Kaplan-Meier Survival Curves for the Combined Outcome of Heart Failure Hospitalization, Cardiovascular Hospitalization, or Death, Stratified by Left Ventricular Geometry Group
Patients with eccentric hypertrophy had outcomes that were similar to patients with concentric hypertrophy (Log-rank P=0.33).Patients with left ventricular hypertrophy (either eccentric or concentric hypertrophy) had worse outcomes compared to those without left ventricular hypertrophy (Log-rank P=0.0005).

Similar articles

Cited by

References

    1. Komajda M, Carson PE, Hetzel S, McKelvie R, McMurray J, Ptaszynska A, Zile MR, Demets D, Massie BM. Factors associated with outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE) Circ Heart Fail. 2011;4:27–35. - PubMed
    1. Zile MR, Baicu CF, Gaasch WH. Diastolic heart failure--abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med. 2004;350:1953–1959. - PubMed
    1. Maurer MS, King DL, El-Khoury Rumbarger L, Packer M, Burkhoff D. Left heart failure with a normal ejection fraction: identification of different pathophysiologic mechanisms. J Card Fail. 2005;11:177–187. - PubMed
    1. Shah AM, Pfeffer MA. The many faces of heart failure with preserved ejection fraction. Nat Rev Cardiol. 2012;9:555–556. - PubMed
    1. Maurer MS, Burkhoff D, Fried LP, Gottdiener J, King DL, Kitzman DW. Ventricular structure and function in hypertensive participants with heart failure and a normal ejection fraction: the Cardiovascular Health Study. J Am Coll Cardiol. 2007;49:972–981. - PubMed

Publication types

MeSH terms